Cardio Diagnostics Holdings is trading 15.4% up at $2.30 in pre-market, based on the provided quote, ahead of its August 20, 2026 investor call.
- The call will cover cardiovascular diagnostic tests, clinical studies, reimbursement progress, and growth initiatives.
- Its newly launched Iowa laboratory remains a recent strategic catalyst.
- Healthcare-sector strength may be contributing, but no definitive new overnight company announcement was identified.